Company Overview of Novasite Pharmaceuticals, Inc.
Novasite Pharmaceuticals, Inc. engages in the discovery and development of drugs for diseases that affect the central nervous system. It also develops G protein coupled receptor modulating drugs. Novasite’s drug discovery pipeline includes Dopamine Reuptake Inhibitor, which is in phase II; and cannabinoid receptor, a preclinical stage drug, which is used to treat neuropathic pain. The company is based in San Diego, California. Novasite Pharmaceuticals, Inc. operates as a subsidiary of Applied Molecular Evolution, Inc.
11025 Roselle Street
San Diego, CA 92121
Key Executives for Novasite Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Novasite Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.